Literature DB >> 11377471

Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.

N Basara1, M G Kiehl, W Blau, E Römer, M Bischoff, B Schmetzer, D Kirsten, S Günzelmann, A A Fauser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11377471     DOI： 10.1016/s0041-1345(01)01968-6

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  14 in total

1.  Low-dose antithymocyte globulin for treatment of steroid-pulse-resistant acute graft-versus-host disease.

Authors:  Kazuteru Ohashi; Yuji Tanaka; Shin-ichiro Mori; Yoshiki Okuyama; Kiyoshi Hiruma; Hideki Akiyama; Hisashi Sakamaki
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

Review 2.  Mycophenolate mofetil: fully utilizing its benefits for GvHD prophylaxis.

Authors:  Kentaro Minagawa; Motohiro Yamamori; Yoshio Katayama; Toshimitsu Matsui
Journal:  Int J Hematol       Date:  2012-05-17       Impact factor: 2.490

3.  A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease.

Authors:  Chie Onishi; Kazuteru Ohashi; Takeshi Sawada; Mikako Nakano; Takeshi Kobayashi; Takuya Yamashita; Hideki Akiyama; Hisashi Sakamaki
Journal:  Int J Hematol       Date:  2010-03-10       Impact factor: 2.490

Review 4.  Pathogenesis and management of graft-versus-host disease.

Authors:  Sung W Choi; John E Levine; James L M Ferrara
Journal:  Immunol Allergy Clin North Am       Date:  2010-02       Impact factor: 3.479

Review 5.  Management of acute graft-versus-host disease in children.

Authors:  Paul A Carpenter; Margaret L Macmillan
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

6.  Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease.

Authors:  Akiyoshi Takami; Kanako Mochizuki; Hirokazu Okumura; Satsuki Ito; Yukio Suga; Hirohito Yamazaki; Masahide Yamazaki; Yukio Kondo; Hidesaku Asakura; Shinji Nakao
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

Review 7.  Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation.

Authors:  Melissa Young; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

8.  Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

Authors:  Paul J Martin; Barry E Storer; Scott D Rowley; Mary E D Flowers; Stephanie J Lee; Paul A Carpenter; John R Wingard; Paul J Shaughnessy; Marcel P DeVetten; Madan Jagasia; Joseph W Fay; Koen van Besien; Vikas Gupta; Carrie Kitko; Laura J Johnston; Richard T Maziarz; Mukta Arora; Pamala A Jacobson; Daniel Weisdorf
Journal:  Blood       Date:  2009-03-06       Impact factor: 22.113

Review 9.  Acute graft-versus-host disease: new treatment strategies.

Authors:  Sophie Paczesny; Sung W Choi; James L M Ferrara
Journal:  Curr Opin Hematol       Date:  2009-11       Impact factor: 3.284

10.  Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP).

Authors:  Madan H Jagasia; Bipin N Savani; George Stricklin; Brian Engelhardt; Adetola Kassim; Sheri Dixon; Heidi Chen; Wichai Chinratanalab; Stacey Goodman; John P Greer; Friedrich Schuening
Journal:  Biol Blood Marrow Transplant       Date:  2009-08-03       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.